Ranbaxy's Patent Litigations in the United States
ICMR HOME | Case Studies Collection
This case study was compiled from published sources, and is intended to be used as a basis for class discussion. It is not intended to illustrate either effective or ineffective handling of a management situation. Nor is it a primary information source.
It ends with a note on Ranbaxy's challenges in meeting its target of $ 2 billion for the year 2007..
» Growth strategy of a pharmaceutical company in the international market
Ranbaxy Laboratories Limited, Pfizer, Lipitor, Teva Pharmaceuticals USA Inc., Glaxo Wellcome, Patent Litigations, Drug Price Control Order, Indian Patent Act of 1970, Ranbaxy Pharmaceuticals Inc., Food and Drug Administration (FDA), Generics, Patent and Trademark Office, Pharmaceutical Industry, Hatch-Waxman Act, Abbreviated New Drug Application, Paragraph IV (Para IV) certification, Eli Lilly, Cefaclor, Patent, Dr. Reddy's Laboratories
Case Studies Links:-
Short Case Studies,
Simplified Case Studies.
Other Case Studies:- Multimedia Case Studies, Cases in Other Languages.
Business Reports Link:- Business Reports.
Books:- Textbooks, Work Books, Case Study Volumes.
|Business Environment||Business Ethics||Business Reports||Business Strategy|
|Corporate Governance||Economics||Enterprise Risk Management||Finance|
|HRM||Innovation||Insurance||IT and Systems|
|Leadership and Entrepreneurship||Marketing||Miscellaneous||Operations|
|Project Management||Short Case Studies||Cases in other Languages||Free Case Studies|